Insider Transactions in Q1 2025 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
7,225
-1.05%
|
$122,825
$17.89 P/Share
|
|
Mar 27
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,864
-0.41%
|
$48,688
$17.89 P/Share
|
|
Mar 27
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,430
-0.69%
|
$585,310
$17.89 P/Share
|
|
Mar 27
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,744
-0.46%
|
$114,648
$17.89 P/Share
|
|
Mar 27
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
11,152
-0.47%
|
$189,584
$17.89 P/Share
|
|
Mar 20
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,734
-4.99%
|
$454,478
$17.22 P/Share
|
|
Mar 19
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
6,694
-1.31%
|
$107,104
$16.53 P/Share
|
|
Mar 19
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,632
-1.66%
|
$122,112
$16.53 P/Share
|
|
Mar 19
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
16,535
-0.35%
|
$264,560
$16.53 P/Share
|
|
Mar 19
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,266
-0.76%
|
$132,256
$16.53 P/Share
|
|
Mar 19
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
11,016
-1.23%
|
$176,256
$16.53 P/Share
|
|
Mar 19
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
6,602
-0.48%
|
$105,632
$16.53 P/Share
|
|
Mar 19
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,234
-0.51%
|
$115,744
$16.53 P/Share
|
|
Mar 19
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,101
-0.34%
|
$545,616
$16.53 P/Share
|
|
Mar 19
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,432
-0.39%
|
$182,912
$16.53 P/Share
|
|
Mar 18
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,888
-2.07%
|
$78,208
$16.89 P/Share
|
|
Mar 18
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,114
-1.12%
|
$433,824
$16.89 P/Share
|
|
Mar 18
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
6,725
-1.47%
|
$107,600
$16.89 P/Share
|
|
Mar 18
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.48%
|
$425,000
$17.01 P/Share
|
|
Mar 18
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,923
-0.55%
|
$62,768
$16.89 P/Share
|
|
Mar 18
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,535
-0.55%
|
$440,560
$16.89 P/Share
|
|
Mar 18
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,815
-0.92%
|
$221,040
$16.89 P/Share
|
|
Mar 17
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.23%
|
$450,000
$15.99 P/Share
|
|
Mar 13
2025
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+3.32%
|
-
|
|
Mar 13
2025
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,484
+12.03%
|
-
|
|
Mar 13
2025
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+1.06%
|
-
|
|
Mar 13
2025
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+4.04%
|
-
|
|
Mar 13
2025
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+8.69%
|
-
|
|
Mar 13
2025
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+11.68%
|
-
|
|
Mar 13
2025
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+5.24%
|
-
|
|
Mar 13
2025
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,868
+6.38%
|
-
|
|
Mar 13
2025
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,548
+5.88%
|
-
|
|
Mar 13
2025
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,065
+9.64%
|
-
|
|
Mar 13
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,789
+13.39%
|
-
|
|
Mar 13
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+13.37%
|
-
|
|
Mar 13
2025
|
Dawn Christine Maroney President |
BUY
Grant, award, or other acquisition
|
Direct |
170,968
+6.53%
|
-
|
|
Mar 13
2025
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338,710
+6.32%
|
-
|
|
Mar 13
2025
|
Andreas P. Wagner Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,109
+12.95%
|
-
|
|
Mar 12
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
5,313
-0.39%
|
$79,695
$15.58 P/Share
|
|
Mar 12
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,122
-0.56%
|
$796,830
$15.58 P/Share
|
|
Mar 12
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,692
-0.52%
|
$220,380
$15.58 P/Share
|
|
Mar 12
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,243
-0.59%
|
$408,645
$15.58 P/Share
|
|
Mar 12
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,856
-0.36%
|
$72,840
$15.58 P/Share
|
|
Mar 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-2.06%
|
$1,350,000
$15.54 P/Share
|
|
Mar 07
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,574
-2.13%
|
$323,610
$15.35 P/Share
|
|
Mar 06
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
55,403
-7.6%
|
$831,045
$15.53 P/Share
|